Module 2 - Management of Atopic Dermatitis in Adult Patients

Knowledge of clinical, economic, and humanistic burden of atopic dermatitis in adults, and recommended treatments, can empower managed care and payer decision makers toward implementing health care benefit policy strategies to reduce disease burden and enhance treatment outcomes.

Heather Woolery-Lloyd, MD, FAAD

Director, Skin of Color Division
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery
University of Miami Miller School of Medicine

Heather Woolery-Lloyd, MD, FAAD is a board-certified dermatologist and is also board-certified in Lifestyle Medicine.

Dr. Woolery-Lloyd is an internationally recognized dermatology and wellness expert. She has been featured in various publications including Forbes, The Wall Street Journal, and The New York Times.

Dr. Woolery-Lloyd has lectured at national and international conferences on dermatology, skincare, and wellness. She founded DermFriends, a platform that provides a reliable source of skincare education and expert recommendations for common skin, hair, and nail concerns.

Dr. Woolery-Lloyd participates extensively in clinical research, serving as an investigator in dozens of FDA clinical trials with an emphasis on increasing the inclusion of skin of color patients.

Dr. Woolery-Lloyd practices dermatology in both a private practice and an academic setting. She currently serves as Director of the Skin of the Color Division for the University of Miami Department of Dermatology. She also is an active member of the Skin of Color Society and the American Academy of Dermatology.

1.
Explain the challenges pediatric and adult patients’ experience with moderate-to-severe atopic dermatitis and the recommended treatment options
2.
Assess opportunities to collaborate and apply fair drug coverage policies to atopic dermatitis treatments
3.
Identify opportunities to address elements that contribute to the disparities in access and outcomes in atopic dermatitis